Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Medimscience Biomedical Technology is a specialized medical technology company focused on the development and manufacturing of high-end minimally invasive interventional devices. The company primarily operates in the fields of cardiovascular, peripheral vascular, and neurovascular health, providing innovative solutions such as drug-eluting stents and drug-coated balloons. Medimscience leverages proprietary drug-loading and surface coating technologies to improve the biocompatibility and therapeutic efficacy of its vascular implants. Based in Hangzhou, China, the company aims to provide high-quality domestic alternatives to international interventional products, supported by a robust R&D pipeline and GMP-certified manufacturing facilities. Their portfolio addresses critical needs in treating obstructive vascular diseases and improving patient outcomes in interventional cardiology and radiology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Medimscience Biomedical Technology.